ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value ($000): $456,751 (100.0% shares, 0.0% debt)

Holdings (19)

— QUIDEL CORP 27.2%

Value ($000) $124,055 Shares 1,903,558 Est. Cost $25223.83 Unrealized —

— ACCELERATE DIAGNOSTICS INC 21.0%

Value ($000) $96,095 Shares 4,187,145 Est. Cost $22.30 Unrealized —

— AMARIN CORP PLC 20.8%

Value ($000) $95,182 Shares 5,850,151 Est. Cost $603.60 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 11.1%

Value ($000) $50,787 Shares 9,387,634 Est. Cost $4.84 Unrealized -11.3%

— TESARO INC 4.4%

Value ($000) $20,177 Shares 517,235 Est. Cost $12435.97 Unrealized —

— BIOLASE INC 2.8%

Value ($000) $12,779 Shares 6,173,250 Est. Cost $1.21 Unrealized —

OPK OPKO HEALTH INC 2.8%

Value ($000) $12,754 Shares 3,686,194 Est. Cost $7.29 Unrealized -27.8%

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 2.7%

Value ($000) $12,170 Shares 897,494 Est. Cost $8.65 Unrealized —

— CONTRAFECT CORP 1.9%

Value ($000) $8,798 Shares 4,250,384 Est. Cost $2.52 Unrealized —

— VERMILLION INC 1.5%

Value ($000) $6,976 Shares 9,825,289 Est. Cost $1445.80 Unrealized —

— SOLENO THERAPEUTICS INC 1.2%

Value ($000) $5,266 Shares 2,438,060 Est. Cost $1.81 Unrealized —

— AGENUS INC 0.7%

Value ($000) $3,209 Shares 1,499,540 Est. Cost $2.27 Unrealized —

— ACCELERATE DIAGNOSTICS INC 0.7%

Value ($000) $2,993 Shares 967,900 Est. Cost $22.30 Unrealized —

BIIB BIOGEN INC 0.5%

Value ($000) $2,250 Shares 6,368 Est. Cost $213.68 Unrealized +61.1%

VRAYQ VIEWRAY INC 0.4%

Value ($000) $2,030 Shares 216,862 Est. Cost $9.83 Unrealized 0.0%

— ADURO BIOTECH INC 0.2%

Value ($000) $820 Shares 111,542 Est. Cost $8.85 Unrealized —

— EPIZYME INC 0.1%

Value ($000) $306 Shares 28,884 Est. Cost $17.56 Unrealized —

— QUIDEL CORP 0.0%

Value ($000) $58 Shares 175,000 Est. Cost $25223.83 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 0.0%

Value ($000) $46 Shares 50,000 Est. Cost $4.84 Unrealized -11.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	QUIDEL CORP	1,903,558	$124,055	27.2%	$25223.83	—	COM	74838J101
—	ACCELERATE DIAGNOSTICS INC	4,187,145	$96,095	21.0%	$22.30	—	COM	00430H102
—	AMARIN CORP PLC	5,850,151	$95,182	20.8%	$603.60	—	SPONS ADR NEW	023111206
PACB	PACIFIC BIOSCIENCES CALIF IN	9,387,634	$50,787	11.1%	$4.84	-11.3%	COM	69404D108
—	TESARO INC	517,235	$20,177	4.4%	$12435.97	—	COM	881569107
—	BIOLASE INC	6,173,250	$12,779	2.8%	$1.21	—	COM NEW	090911207
OPK	OPKO HEALTH INC	3,686,194	$12,754	2.8%	$7.29	-27.8%	COM	68375N103
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	897,494	$12,170	2.7%	$8.65	—	SPONDS ADR	00653A107
—	CONTRAFECT CORP	4,250,384	$8,798	1.9%	$2.52	—	COM	212326102
—	VERMILLION INC	9,825,289	$6,976	1.5%	$1445.80	—	COM NEW	92407M206
—	SOLENO THERAPEUTICS INC	2,438,060	$5,266	1.2%	$1.81	—	COM NEW	834203200
—	AGENUS INC	1,499,540	$3,209	0.7%	$2.27	—	COM NEW	00847G705
—	ACCELERATE DIAGNOSTICS INC	967,900	$2,993	0.7%	$22.30	—	Call	00430H102
BIIB	BIOGEN INC	6,368	$2,250	0.5%	$213.68	+61.1%	COM	09062X103
VRAYQ	VIEWRAY INC	216,862	$2,030	0.4%	$9.83	0.0%	COM	92672L107
—	ADURO BIOTECH INC	111,542	$820	0.2%	$8.85	—	COM	00739L101
—	EPIZYME INC	28,884	$306	0.1%	$17.56	—	COM	29428V104
—	QUIDEL CORP	175,000	$58	0.0%	$25223.83	—	Call	74838J101
PACB	PACIFIC BIOSCIENCES CALIF IN	50,000	$46	0.0%	$4.84	-11.3%	Call	69404D108